ORange Wavefront Aberrometer Proves Successful in Determining Refraction in Cataract Patients Who Previously Had LASIK Surgery

ALISO VIEJO, Calif.--(BUSINESS WIRE)--WaveTec Vision, the leader in wavefront-guided custom cataract™ surgery, announced today that its ORange® intraoperative wavefront aberrometer has been shown to be more predictable in determining refraction in the post-refractive eye, than any other post-LASIK formula currently available.

“Following LASIK, patients expect a lifetime of quality uncorrected vision. Unfortunately, these same patients are the most difficult to predict the optimal IOL power when they develop cataracts”

Wavefront custom cataract aberrometry with ORange is a breakthrough in modern cataract surgery. The technology has been clinically proven to increase accuracy and improve refractive outcomes: 73 percent of procedures are within 0.5D of intended target, versus 58 percent with traditional cataract surgery using standard method biometry.

A patented diagnostic breakthrough, ORange allows cataract surgeons – for the first time – to measure refraction during surgery, so they can precisely predict and customize how their patients will see following the procedure.

source: Business Wire

Technolas Perfect Vision Receives FDA Approval of Latest Technology for Custom LASIK

MUNICH, GERMANY--(Marketwire - March 14, 2011) - Technolas Perfect Vision GmbH (TPV), a cataract and refractive laser company at the forefront of providing advanced eye laser treatments, today announced that the U.S. Food and Drug Administration (FDA) has approved the ZYOPTIX® Advanced Nomogram. The Advanced Nomogram is the latest, state-of-the-art methodology for use in custom LASIK eye surgery procedures when treating nearsightedness and astigmatism. This confirms that "there is convincing evidence that LASIK myopia corrections are more accurate with the Advanced Nomogram than without it."

Using the Advanced Nomogram when performing custom LASIK with the TECHNOLAS 217z100 laser, significantly improves the predictability of the results, as well as reducing the possibility of requiring a second enhancement procedure. Technolas Perfect Vision is the ONLY company in the US able to offer this latest, approved technology for LASIK on their laser platform.

The Advanced Nomogram was developed in collaboration with the Center for Visual Science, at the University of Rochester Flaum Eye Institute.

source: Technolas Perfect Vision

BIOLASE Issued New Patent Supporting Use of Laser Technologies for Treating Eye Conditions

BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that the U.S. Patent and Trademark Office has issued BIOLASE a new patent covering the use of its laser technologies for treating various conditions of the eye, including presbyopia. The patent is related to applying dyes and colored lighting to make structures in the eye more visible for various eye procedures performed with the Company's patented laser technologies. In addition, certain colorings allow for greater absorption of energy making it easier to cut at lower energy settings.

The patent is number 7,891,363 and is titled "Methods for Treating Eye Conditions." It supports previously issued patents and covers methods for treating eye disorders, such as presbyopia, the age-related loss of near vision that comes to everyone in mid-life. Presbyopia generally signifies a universal decrease in the amplitude of accommodation in the eye and currently affects over 100 million people in the U.S. and more than 2 billion people worldwide.

source: Biolase